Provided are lactam-cyclized peptide CXCR4 antagonists useful in the treatment of cancers, rheumatoid arthritis, pulmonary fibrosis, and HIV infection.

 
Web www.patentalert.com

< Method of producing recombinant antithrombin III composition

> Methods for blocking TNF-alpha activity in mammals with trimeric soluble TNF receptors

> Peptidomimetic inhibitors of retroviral proteases and their use as antivirals
~ 00595